The hidden face of venous malformations: A multidisciplinary therapeutic approach

Archives of Dermatology

Volumn 144, Issue 7, 2008, Pages 922-926

  Redondo, Pedro ^a  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ALENDRONIC ACID; ANGIOPOIETIN 1; ANGIOPOIETIN 2; ANTICOAGULANT AGENT; D DIMER; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; PARATHYROID HORMONE[1-34]; POLIDOCANOL; RISEDRONIC ACID; TETRADECYL SULFATE SODIUM; VASCULOTROPIN;

ANGIOGENESIS; ANGIOGRAPHY; ANGIOOSTEOHYPERTROPHY SYNDROME; BLEEDING TENDENCY; BLOOD CLOTTING; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE COURSE; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG EFFICACY; DRUG MECHANISM; ECHOGRAPHY; EDITORIAL; FIBRINOLYSIS; HEMANGIOMA; HEMOSTASIS; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; MAGNETIC RESONANCE ANGIOGRAPHY; MULTIDETECTOR COMPUTED TOMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOPOROSIS; PHLEBOGRAPHY; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SCLEROTHERAPY; THREE DIMENSIONAL IMAGING; THROMBOSIS; TREATMENT OUTCOME; VEIN MALFORMATION;

BLOOD COAGULATION DISORDERS; COMBINED MODALITY THERAPY; DECISION SUPPORT TECHNIQUES; HUMANS; VASCULAR MALFORMATIONS;

EID: 47849114598     PISSN: 0003987X     EISSN: 0003987X     Source Type: Journal    
DOI: 10.1001/archderm.144.7.922     Document Type: Editorial

References (42)

1. Enjolras O, Mulliken JB. Vascular malformations. In: Harper J, Oranje A, Prose N, eds. Textbook of Pediatric Dermatology. Oxford, England: Blackwell Sciences Ltd; 2000:975-977.
2. Mulliken JB, Glowacki J. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg. 1982;69(3):412-419.
3. Konez O, Burrows PE. Magnetic resonance of vascular anomalies. Magn Reson Imaging Clin N Am. 2002;10(2):363-388.
4. Napoli A, Fleischmann D, Chan FP, et al. Computed tomography angiography: state-of-the-art imaging using multidetector-row technology. J Comput Assist Tomogr. 2004;28(suppl 1):S32-S45.
5. Nael K, Laub G, Finn JP. Three-dimensional contrast-enhanced MR angiography of the thoraco-abdominal vessels. Magn Reson Imaging Clin N Am. 2005; 13(2):359-380.
6. Bastarrika G, Redondo P, Sierra A, et al. New techniques for the evaluation and therapeutic planning of patients with Klippel-Trenaunay syndrome. J Am Acad Dermatol. 2007;56(2):242-249.
7. Hein KD, Mulliken JB, Kozakewich HP, Upton J, Burrows PE. Venous malformations of skeletal muscle. Plast Reconstr Surg. 2002;110(7):1625-1635.
8. Dompmartin A, Acher A, Thibon P, et al. Association of localized intravascular coagulopathy with venous malformations. Arch Dermatol. 2008;144(7):873-877.
9. Mazoyer E, Enjolras O, Bisdorff A, Perdu J, Wassef M, Drouet L. Coagulation disorders in patients with venous malformation of the limbs and trunk: a case series of 118 patients. Arch Dermatol. 2008;144(7):861-867.
10. Enjolras O, Ciabrini D, Mazoyer E, et al. Extensive pure venous malformations in the upper or lower limb, a review of 27 cases. J Am Acad Dermatol. 1997;36 (2, pt 1):219-225.
11. Boyd JB, Mulliken JB, Kaban LB, Upton J, Murray JE. Skeletal changes associated with vascular malformations. Plast Reconstr Surg. 1984;74(6):789-797.
12. Eimori K, Ogose A, Hotta T, Kawashima H, Omori G, Endo N. Treatment of pathological fracture of the femur due to diffuse haemangioma in the lower limb. J Bone Joint Surg Br. 2005;87(3):412-414.
13. Benchakroun M, Ouadghiri M, Berrada S, et al. Pathological fracture of the femur in a patient with a venous malformation. Rev Chir Orthop Reparatrice Appar Mot. 2004;90(3):280-284.
14. Plotkin LI, Weinstein TS, Parfitt AM, et al. Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin. J Clin Invest. 1999;104 (10):1363-1374.
15. Hodsman AB, Bauer DC, Dempster D, et al. Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use. Endocr Rev. 2005;26(5):688-703.
16. Mazoyer E, Enjolras O, Laurian C, Houdart E, Drouet L. Coagulation abnormalities associated with extensive venous malformations of the limbs: differentiation from Kasabach-Merritt syndrome. Clin Lab Haematol. 2002;24(4):243-251.
17. Kelly J, Rudd A, Lewis RR, Hunt BJ. Plasma D-dimers in the diagnosis of venous thromboembolism. Arch Intern Med. 2002;162(7):747-756.
18. Eikelboom JW, Hankey GJ. Low molecular weight heparin and heparinoids. Med J Aust. 2002;177(7):379-383.
19. Ahmed I, Majeed A, Powell R. Heparin induced thrombocytopenia: diagnosis and management update. Postgrad Med J. 2007;83(983):575-582.
20. Rajgopal R, Bear M, Butcher MK, Shaughnessy SG. The effects of heparin and low molecular weight heparins on bone [published online August 21, 2007] Thromb Res. doi:10.1016/j.thromres.2006.10.025.
21. Marler JJ, Fishman SJ, Kilroy SM, et al. Increased expression of urinary matrix metalloproteinases parallels the extent and activity of vascular anomalies. Pediatrics. 2005;116(1):38-45.
22. Meijer-Jorna LB, van der Loos CM, de Boer OJ, van der Horst CMAM, van der Wasl AC. Microvascular proliferation in congenital vascular malformations of skin and soft tissue. J Clin Pathol. 2007;60(7):798-803.
23. Lobov IB, Brooks PC, Lang RA. Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo. Proc Natl Acad Sci U S A. 2002;99(17):11205-11210.
24. Fiedler U, Scharpfenecker M, Koidl S, et al. The Tie-2 ligand angiopoietin-2 is stored in and rapidly released upon stimulation from endothelial cell Weibel-Palade bodies. Blood. 2004;103(11):4150-4156.
25. Kisucka J, Butterfield CE, Duda DG, et al. Platelets and platelet adhesion support angiogenesis while preventing excessive hemorrhage. Proc Natl Acad Sci U S A. 2006;103(4):855-860.
26. Moser M, Patterson C. Thrombin and vascular development. Arterioscler Thromb Vasc Biol. 2003;23(6):922-930.
27. Bikfalvi A, Klein S, Pintucci G, Rifkin D. The roles of proteases in angiogenesis. In: Bicknell R, Lewis C, Ferrara N, eds. Tumor Angiogenesis. Oxford, England: Oxford University Press; 1997:115-124.
28. Norrby K. Low-molecular weight heparins and angiogenesis. APMIS. 2006;114 (2):79-102.
29. Lee AYY, Rickles FR, Julian JA, et al. randomized comparison of low molecular weight heparin and coumarin derivatives on the survival of patients with cancer and venous thromboembolism. J Clin Oncol. 2005;23(10):2123-2129.
30. Di Nisio M, Klerk CP, Meijers JC, Büller HR. The prognostic value of the D-dimer test in cancer patients treated with and without low-molecular-weight heparin. J Thromb Haemost. 2005;3(7):1531-1533.
31. Villavicencio JL. Primum non nocere: is it always true? the use of absolute ethanol in the management of congenital vascular malformations. J Vasc Surg. 2001; 33(4):904-906.
32. Lee BB, Kim DI, Huh S, et al. New experiences with absolute ethanol sclerotherapy in the management of a complex form of congenital venous malformation. J Vasc Surg. 2001;33(4):764-772.
33. Redondo P, Cabrera J. Microfoam sclerotherapy. Semin Cutan Med Surg. 2005; 24(4):175-183.
34. Cabrera J, Cabrera J Jr, Garc?́a-Olmedo MA, Redondo P. Treatment of venous malformations with sclerosant in microfoam form. Arch Dermatol. 2003;139 (11):1409-1416.
35. Hsu TS, Weiss RA. Foam sclerotherapy: a new era. Arch Dermatol. 2003;139(11): 1494-1496.
36. Nitecki S, Bass A. Ultrasound-guided foam sclerotherapy in patients with Klippel-Trenaunay syndrome. Isr Med Assoc J. 2007;9(2):72-75.
37. Bergan J, Pascarella L, Mekenas L. Venous disorders: treatment with sclerosant foam. J Cardiovasc Surg (Torino). 2006;47(1):9-18.
38. Nachman RL, Silverstein R. Hypercoagulable states. Ann Intern Med. 1993;119 (8):819-827.
39. Yamaki T, Nozaki M, Sasaki K. Color duplex-guided sclerotherapy for the treatment of venous malformations. Dermatol Surg. 2000;26(4):323-328.
40. Fujii Y, Sugawa C, Ozawa T, Nakumura R, Brown-Castillo J, Mammen EF. Hemostasis activation during esophageal variceal sclerotherapy with thrombin in cirrhotics. Am Surg. 1991;57(4):222-225.
41. Mason KP, Neufeld EJ, Karian VE, Zurakowski D, Koka BV, Burrows P. Coagulation abnormalities in pediatric and adult patients after sclerotherapy or embolization of vascular anomalies. AJR Am J Roentgenol. 2001;177(6):1359-1363.
42. Ikeda M, Kambayashi J, Iwamoto S, et al. The coagulofibrinolytic state of patients with primary varicose veins of the lower legs. Surg Today. 1996;26(12): 985-989.